ReviewCommunications chemistry2026
Advances in solid handling for continuous flow synthesis of specialty chemicals and pharmaceuticals.
Review in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Continuous flow chemistry has transformed the synthesis of pharmaceuticals and specialty chemicals by advancing sustainability, efficiency, and process control. Despite these advantages, the management of solids remains a major challenge, often leading to clogging, inefficient mixing, and limitations in scalability. This review discusses recent strategies developed to overcome these obstacles, including the use of continuous stirred-tank reactors, packed-bed reactors with immobilized reagents, reaction design modifications, Pickering emulsions, colloidal nanoparticle suspensions, and specialised equipment such as agitated tubular reactors, spinning disk reactors, and sonicated systems. By critically assessing these developments, we chart the trajectory toward more resilient and robust flow-based manufacturing, consolidating continuous flow chemistry as a cornerstone of modern chemical manufacturing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.